Research Blogs

 

 

Research Strategy Blog- What is “Full-Spectrum Research”?

Steve Kaminsky, PhD, Chief Science Officer Rettsyndrome.org, April, 2017

What is ‘full spectrum’ research and how does it differentiate Rettsyndrome.org? It is identifying the best genetic and pharmacologic research to correct the biology of the brain’s neurons, while also studying how to reset the neurology - the neural pathway development- through physical, occupational, speech and cognitive therapies.

 

 

Clinical Trials: Understanding their importance and how to participate

Steve Kaminsky, PhD, Chief Science Officer Rettsyndrome.org, January 2017

Click here to read Dr. K's blog answering your most pressing questions about clinical trials

 

 

An update from our Chief Science Officer

Steve Kaminsky, PhD, Chief Science Officer Rettsyndrome.orgFebruary 5, 2016

As we begin 2016 our research strategy remains consistent – to cover the full spectrum of Rett syndrome research from basic discovery, where ideas begin, to translating discoveries into medicines for future clinical testing and treatments.

 

 

Impatient Revolution:  A guide for impatient patient organizations

Ana Mingorance, PhD, Dracaena Consulting, April 5, 2017

Read Dr. Mingorance's perspective on non-profit fundraising organizations, their research, and their clinical trials.

 

Trofinetide for Rett Syndrome in Recent News

Public release: June 22, 2015

A novel agent is holding out some much-needed promise for girls and women with Rett syndrome.

 

 

Accelerating Research: "We are in the Time of Rett"

Steve Kaminsky, PhD, Chief Science Officer Rettsyndrome.org

Today, we want to share HOW committed we are to the work scientists and clinicians are doing to find treatments and a cure for Rett syndrome.